LAUDA DR. R. WOBSER GMBH & CO. KG
Antonio Manconi Ten Years With LAUDA Italia
more
Stories about Pharmaindustrie
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
moreGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
moreGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
moreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more- 2
Record financing rounds at the Munich biotech hub
One documentmore Bosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
morePress release: STADA continues strong growth journey in the first half of 2024
One documentmore- 2
Cool Concept for International Logistics / Mannheim/Germany-based eutecma GmbH with Second Location in the USA
more - 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more - 10
Gerresheimer: New pictures available
more LAUDA DR. R. WOBSER GMBH & CO. KG
5ACHEMA 2024: LAUDA Looks Back on a Successful Exhibition
moreBayer Collaborates with PAPACKS to Co-create Alternative-to-Plastic Packaging for Consumer Health Products
moreGerresheimer expands capacities for Medical Systems in the USA
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
morePress release: STADA continues with double-digit sales and profit growth in 2023
One documentmore- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
more Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
moreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreSHL Medical partners with SteriPack Group to set up final assembly service
moreSHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.
morePress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
One documentmoreLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
moreFraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
moreSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
moreBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
more
12Next